Literature DB >> 16247069

Treatment delay and the risk of prolonged status epilepticus.

K Eriksson1, P Metsäranta, H Huhtala, A Auvinen, A-L Kuusela, M Koivikko.   

Abstract

Factors contributing to the duration of a single convulsive seizure > 5 minutes were analyzed in 157 children. The medically treated episodes were compared with seizure episodes resolving without treatment (n = 27). Major differences were in age (p = 0.016) and etiology (p = 0.003), and the association between treatment delay and response became significant after 30 minutes when this was analyzed as a single variable (p = 0.003) in Cox regression analysis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16247069     DOI: 10.1212/01.wnl.0000180959.31355.92

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  33 in total

1.  Treatment of refractory status epilepticus in childhood.

Authors:  John M Schreiber; William D Gaillard
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

Review 2.  Lessons from the laboratory: the pathophysiology, and consequences of status epilepticus.

Authors:  Karthik Rajasekaran; Santina A Zanelli; Howard P Goodkin
Journal:  Semin Pediatr Neurol       Date:  2010-09       Impact factor: 1.636

3.  Mortality prediction in status epilepticus with the APACHE II score.

Authors:  Jocelyn Y Cheng
Journal:  J Intensive Care Soc       Date:  2017-06-26

Review 4.  Medication Use in Schools: Current Trends, Challenges, and Best Practices.

Authors:  Susan M Butler; Elizabeth A Boucher; Jennifer Tobison; Hanna Phan
Journal:  J Pediatr Pharmacol Ther       Date:  2020 Jan-Feb

5.  Time from convulsive status epilepticus onset to anticonvulsant administration in children.

Authors:  Iván Sánchez Fernández; Nicholas S Abend; Satish Agadi; Sookee An; Ravindra Arya; James Nicholas Brenton; Jessica L Carpenter; Kevin E Chapman; William D Gaillard; Tracy A Glauser; Howard P Goodkin; Kush Kapur; Mohamad A Mikati; Katrina Peariso; Margie Ream; James Riviello; Robert C Tasker; Tobias Loddenkemper
Journal:  Neurology       Date:  2015-05-06       Impact factor: 9.910

6.  Management of pediatric status epilepticus.

Authors:  Nicholas S Abend; Tobias Loddenkemper
Journal:  Curr Treat Options Neurol       Date:  2014-07       Impact factor: 3.598

7.  Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.

Authors:  Richard E Appleton; Naomi Ea Rainford; Carrol Gamble; Shrouk Messahel; Amy Humphreys; Helen Hickey; Kerry Woolfall; Louise Roper; Joanne Noblet; Elizabeth Lee; Sarah Potter; Paul Tate; Nadia Al Najjar; Anand Iyer; Vicki Evans; Mark D Lyttle
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

8.  Refractory Status Epilepticus in Children: Intention to Treat With Continuous Infusions of Midazolam and Pentobarbital.

Authors:  Robert C Tasker; Howard P Goodkin; Iván Sánchez Fernández; Kevin E Chapman; Nicholas S Abend; Ravindra Arya; James N Brenton; Jessica L Carpenter; William D Gaillard; Tracy A Glauser; Joshua Goldstein; Ashley R Helseth; Michele C Jackson; Kush Kapur; Mohamad A Mikati; Katrina Peariso; Mark S Wainwright; Angus A Wilfong; Korwyn Williams; Tobias Loddenkemper
Journal:  Pediatr Crit Care Med       Date:  2016-10       Impact factor: 3.624

9.  Treatment of electrographic seizures and status epilepticus in critically ill children: a single center experience.

Authors:  Nicholas S Abend; Sarah M Sanchez; Robert A Berg; Dennis J Dlugos; Alexis A Topjian
Journal:  Seizure       Date:  2013-04-16       Impact factor: 3.184

10.  Outcomes in 140 critically ill patients with status epilepticus.

Authors:  Stéphane Legriel; Bruno Mourvillier; Nicolas Bele; Jose Amaro; Pierre Fouet; Philippe Manet; François Hilpert
Journal:  Intensive Care Med       Date:  2007-10-27       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.